Aktie 946008 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen GlaxoSmithKline Pharmaceuticals Limited

Aktien

946008

INE159A01016

GLAXO

Markt geschlossen - Bombay S.E.
Andere Börsenplätze
 12:00:50 19.04.2024 		% 5 Tage % 1. Jan.
1’869 INR -1.08% Intraday Chart für GlaxoSmithKline Pharmaceuticals Limited -1.38% -1.50%
29.02. Cynata Therapeutics ernennt Chief Business Officer; Aktien stürzen um 14% ab MT
28.02. Glaxosmithkline Pharmaceuticals Limited ernennt Aparajita Mukherjee Rajput, Technology Lead CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
GlaxoSmithKline Pharmaceuticals Limited Receives Orders from Government Authorities
Cynata Therapeutics Names Chief Business Officer; Shares Plunge 14%
Glaxosmithkline Pharmaceuticals Limited Appoints Aparajita Mukherjee Rajput, Technology Lead
GlaxoSmithKline Pharmaceuticals Sees Sharp Decline in Fiscal Q3 Consolidated Net Profit
GSK India arm's Q3 profit falls on government price cap
GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Sunder Ramachandran as Head of Commercial Excellence, Effective 12 January 2024
GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Abhinav Kashyap as Pharma Technology Lead
GSK registers 5% Growth
GSK's India unit posts Q2 profit rise on strong vaccine demand
GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
GlaxoSmithKline Pharmaceuticals Limited Appoints Omkar Parnandiwar as Head of Omnichannel, Effective November 1, 2023
GSK - General Medicines delivers 4% revenue growth despite NLEM impact along with a sequential recovery in the vaccines business
Glaxosmithkline Pharmaceuticals Records Rise in Fiscal Q1 Consolidated Net Profit
India's GlaxoSmithKline Pharma posts rise in Q1 profit on steady vaccine business
GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Samsung Biologics unveils $920 mln manufacturing deals for Pfizer
A son died, his parents tried to sue. How U.S. courts protect Big Pharma
No habia que invitarlo: GSK
Abbott's India arm posts 9.5% rise in fourth-quarter profit
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 946008 Aktie
  4. Nachrichten GlaxoSmithKline Pharmaceuticals Limited
  5. Andere Sprachen